Transgenic approaches to cancer biology

A R Clarke1

  • 1University of Edinburgh, UK.

Insights

Transgenic animal models using homologous recombination allow researchers to study gene function in tumorigenesis. This technique has been crucial for understanding tumor suppressor genes like Rb and p53.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Transgenic animal models are essential for understanding cancer development.
  • Targeted mutations generated by homologous recombination represent a significant advancement.

Purpose of the Study:

  • To investigate gene function and alterations in situ using homologous recombination.
  • To clarify the roles of tumor suppressor genes Rb and p53 in tumorigenesis.

Main Methods:

  • Utilizing homologous recombination to create targeted mutations in animal models.
  • Applying this technique to study specific tumor suppressor genes, including Rb and p53.

Main Results:

  • Enabled in situ investigation of gene function and consequences of gene alterations.
  • Provided insights into the normal roles of Rb and p53.
  • Elucidated mechanisms by which dysfunction of these genes contributes to cancer.

Conclusions:

  • Homologous recombination in transgenic models is a powerful tool for cancer research.
  • This approach has significantly advanced the understanding of tumor suppressor gene function and cancer mechanisms.

Related Concept Videos

Transgenic Organisms00:53

Transgenic Organisms

Overview
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Transgenic Organisms00:53

Transgenic Organisms

Overview
Transgenic Plants02:50

Transgenic Plants

Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...